1fh9: Difference between revisions

New page: left|200px<br /><applet load="1fh9" size="450" color="white" frame="true" align="right" spinBox="true" caption="1fh9, resolution 1.72Å" /> '''CRYSTAL STRUCTURE OF...
 
No edit summary
Line 1: Line 1:
[[Image:1fh9.jpg|left|200px]]<br /><applet load="1fh9" size="450" color="white" frame="true" align="right" spinBox="true"  
[[Image:1fh9.jpg|left|200px]]<br /><applet load="1fh9" size="350" color="white" frame="true" align="right" spinBox="true"  
caption="1fh9, resolution 1.72&Aring;" />
caption="1fh9, resolution 1.72&Aring;" />
'''CRYSTAL STRUCTURE OF THE XYLANASE CEX WITH XYLOBIOSE-DERIVED LACTAM OXIME INHIBITOR'''<br />
'''CRYSTAL STRUCTURE OF THE XYLANASE CEX WITH XYLOBIOSE-DERIVED LACTAM OXIME INHIBITOR'''<br />


==Overview==
==Overview==
Detailed insights into the mode of binding of a series of tight-binding, aza-sugar glycosidase inhibitors of two fundamentally different classes, are described through X-ray crystallographic studies of complexes with the, retaining family 10 xylanase Cex from Cellulomonas fimi. Complexes with, xylobiose-derived aza-sugar inhibitors of the substituted "amidine" class, (xylobio-imidazole, K(i) = 150 nM; xylobio-lactam oxime, K(i) = 370 nM), reveal lateral interaction of the "glycosidic" nitrogen with the acid/base, catalyst (Glu127) and hydrogen bonding of the sugar 2-hydroxyl with the, catalytic nucleophile (Glu233), as expected. Tight binding of, xylobio-isofagomine (K(i) = 130 nM) appears to be a consequence of strong, interactions of the ring nitrogen with the catalytic nucleophile while, surprisingly, no direct protein contacts are made with the ring nitrogen, of the xylobio-deoxynojirimycin analogue (K(i) = 5800 nM). Instead the, nitrogen interacts with two ordered water molecules, thereby accounting, for its relatively weaker binding, though it still binds some 1200-fold, more tightly than does xylobiose, presumably as a consequence of, electrostatic interactions at the active site. Dramatically weaker binding, of these same inhibitors to the family 11 xylanase Bcx from Bacillus, circulans (K(i) from 0.5 to 1.5 mM) is rationalized for the substituted, amidines on the basis that this enzyme utilizes a syn protonation, trajectory and likely hydrolyzes via a (2,5)B boat transition state., Weaker binding of the deoxynojirimycin and isofagomine analogues likely, reflects the energetic penalty for distortion of these analogues to a, (2,5)B conformation, possibly coupled with destabilizing interactions with, Tyr69, a conserved, catalytically essential active site residue.
Detailed insights into the mode of binding of a series of tight-binding aza-sugar glycosidase inhibitors of two fundamentally different classes are described through X-ray crystallographic studies of complexes with the retaining family 10 xylanase Cex from Cellulomonas fimi. Complexes with xylobiose-derived aza-sugar inhibitors of the substituted "amidine" class (xylobio-imidazole, K(i) = 150 nM; xylobio-lactam oxime, K(i) = 370 nM) reveal lateral interaction of the "glycosidic" nitrogen with the acid/base catalyst (Glu127) and hydrogen bonding of the sugar 2-hydroxyl with the catalytic nucleophile (Glu233), as expected. Tight binding of xylobio-isofagomine (K(i) = 130 nM) appears to be a consequence of strong interactions of the ring nitrogen with the catalytic nucleophile while, surprisingly, no direct protein contacts are made with the ring nitrogen of the xylobio-deoxynojirimycin analogue (K(i) = 5800 nM). Instead the nitrogen interacts with two ordered water molecules, thereby accounting for its relatively weaker binding, though it still binds some 1200-fold more tightly than does xylobiose, presumably as a consequence of electrostatic interactions at the active site. Dramatically weaker binding of these same inhibitors to the family 11 xylanase Bcx from Bacillus circulans (K(i) from 0.5 to 1.5 mM) is rationalized for the substituted amidines on the basis that this enzyme utilizes a syn protonation trajectory and likely hydrolyzes via a (2,5)B boat transition state. Weaker binding of the deoxynojirimycin and isofagomine analogues likely reflects the energetic penalty for distortion of these analogues to a (2,5)B conformation, possibly coupled with destabilizing interactions with Tyr69, a conserved, catalytically essential active site residue.


==About this Structure==
==About this Structure==
1FH9 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Cellulomonas_fimi Cellulomonas fimi]. Active as [http://en.wikipedia.org/wiki/Cellulose_1,4-beta-cellobiosidase Cellulose 1,4-beta-cellobiosidase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.2.1.91 3.2.1.91] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1FH9 OCA].  
1FH9 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Cellulomonas_fimi Cellulomonas fimi]. Active as [http://en.wikipedia.org/wiki/Cellulose_1,4-beta-cellobiosidase Cellulose 1,4-beta-cellobiosidase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.2.1.91 3.2.1.91] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1FH9 OCA].  


==Reference==
==Reference==
Line 16: Line 16:
[[Category: Hoos, R.]]
[[Category: Hoos, R.]]
[[Category: Notenboom, V.]]
[[Category: Notenboom, V.]]
[[Category: Rose, D.R.]]
[[Category: Rose, D R.]]
[[Category: Williams, S.J.]]
[[Category: Williams, S J.]]
[[Category: Withers, S.G.]]
[[Category: Withers, S G.]]
[[Category: catalytic mechanism]]
[[Category: catalytic mechanism]]
[[Category: glycosyl hydrolase family 10]]
[[Category: glycosyl hydrolase family 10]]
Line 24: Line 24:
[[Category: xylanase]]
[[Category: xylanase]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Sat Nov 24 23:49:19 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 12:38:37 2008''

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA